Mats Martinell
Universitetslektor Verksamhetsföreträdare vid Institutionen för folkhälso- och vårdvetenskap; Allmänmedicin
- Mobiltelefon:
- 072-205 17 96
- E-post:
- mats.martinell@pubcare.uu.se
- Besöksadress:
- BMC, Husargatan 3
- Postadress:
- Box 564
751 22 UPPSALA
Universitetslektor vid Institutionen för folkhälso- och vårdvetenskap; Läkarprogrammet
- Mobiltelefon:
- 072-205 17 96
- Besöksadress:
- BMC, Husargatan 3, Uppsala
- Postadress:
- Box 564
751 22 UPPSALA
- Akademiska meriter:
- Leg. läkare
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Jag är verksamhetsföreträdare för forskargruppen allmänmedicin, universitetslektor och distriktsläkare. En del av denna tjänst är att bygga upp akademiska vårdcentraler i Region Uppsala.
2019 delegat i elektorförsamlingen
2020 delegat i läkarprogrammets programkommitté
Nyckelord
- covid-19
- diabetes mellitus
- epidemiology
- type 2 diabetes
Forskning
Min forskning handlar om att underlätta en skräddarsydd diabetesbehandling. Sedan 2012 är jag projektledare för diabetesstudien Alla Nya Diabetiker i Uppsala län (ANDiU). Som ett komplement till ANDiU startade jag 2022 forskningsstudien AUTOMETA-DM med syfte att karakterisera metabola profiler hos personer med prediabetes och diabetes.
Under 2020-2022 var jag ansvarig forskare för projektet CRUSH Covid som beskrev smittspridning av covid-19 i region Uppsala. Sedan 2023 leder jag studien Symptom Genome Project (http://sgp.bio/) som undersöker hur symtomrapportering skiljer sig mellan olika luftvägsvirus.
Publikationer
Senaste publikationer
- DNA methylation partially mediates antidiabetic effects of metformin on HbA1c levels in individuals with type 2 diabetes (2023)
- Sociodemographic characteristics and COVID-19 testingrates: spatiotemporal patterns and impact of testaccessibility in Sweden (2023)
- App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden (2022)
- In-Flight Transmission of a SARS-CoV-2 Lineage B.1.617.2 Harbouring the Rare S:E484Q Immune Escape Mutation (2022)
- Individual goal-based plan based on nursing theory for adults with type 2 diabetes and self-care deficits (2022)
Alla publikationer
Artiklar
- DNA methylation partially mediates antidiabetic effects of metformin on HbA1c levels in individuals with type 2 diabetes (2023)
- Sociodemographic characteristics and COVID-19 testingrates: spatiotemporal patterns and impact of testaccessibility in Sweden (2023)
- App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden (2022)
- In-Flight Transmission of a SARS-CoV-2 Lineage B.1.617.2 Harbouring the Rare S:E484Q Immune Escape Mutation (2022)
- Individual goal-based plan based on nursing theory for adults with type 2 diabetes and self-care deficits (2022)
- Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications (2022)
- Spatio-temporal predictions of COVID-19 test positivity in Uppsala County, Sweden (2022)
- Statin therapy is associated with epigenetic modifications in individuals with type 2 diabetes (2021)
- Epigenetic markers associated with metformin response and intolerance in drug-naive patients with type 2 diabetes (2020)
- Physical Activity, Genetic Susceptibility, and the Risk of Latent Autoimmune Diabetes in Adults and Type 2 Diabetes (2020)
- Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass (2019)
- Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes (2019)
- Novel subgroups of adult-onset diabetes and their association with outcomes (2018)
- Overweight, obesity and the risk of LADA (2018)
- Coffee consumption, genetic susceptibility and risk of latent autoimmune diabetes in adults (2018)
- Clustering of diabetes into novel subgroups provides improved prediction of outcome (2017)
- [(11)C]5-Hydroxy-Tryptophan PET for Assessment of Islet Mass During Progression of Type 2 Diabetes (2017)
- Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA) (2017)
- Overweight, obesity, genetic susceptibility and the risk of LADA (2017)
- Education, immigration and income as risk factors for hemoglobin A1c >70 mmol/mol when diagnosed with type 2 diabetes or latent autoimmune diabetes in adult (2017)
- Sodium intake and the risk of type 2 diabetes and Latent Autoimmune Diabetes in Adults (LADA) (2017)
- Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA) (2017)
- Serious life events and the risk of latent autoimmune diabetes in adults (LADA) and Type 2 diabetes (2017)
- Sweetened beverage intake and risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes (2016)
- Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA) (2016)
- Smoking and the Risk of LADA (2016)
- Betatrophin in Diabetes Mellitus (2015)
- Low birthweight is associated with an increased risk of LADA and type 2 diabetes (2015)
- Family history of type 1 and type 2 diabetes and the risk of LADA-results from a population-based study of incident cases (2014)
- Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes (2014)
- Diabetic retinopathy in All Newly diagnosed Diabetic subjects in Skane (ANDIS), Sweden, during 2008-2013. Baseline findings. (2014)
- Low birth weight is associated with an increased risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes (2014)
- Coffee consumption and the risk of latent autoimmune diabetes in adults-results from a Swedish case-control study (2014)
- Fatty fish consumption and risk of latent autoimmune diabetes in adults (2014)
- Alcohol and the risk for latent autoimmune diabetes in adults (2014)
- Automated data extraction (2012)
- Resource consumption and cost of care the year before and after initiation of insulin theraphy in Swedish patients with type 2 diabetes (2010)
- RESOURCE CONSUMPTION AND COSTS OF CARE THE YEAR BEFORE AND AFTER INITIATION OF INSULIN THERAPY IN SWEDISH PATIENTS WITH TYPE 2 DIABETES (2010)
- Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA) (2010)
- Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes (2010)
- Prevalence of lipid abnormalities before and after the introduction of lipid modifying therapy among Swedish patients with type 2 diabetes and/or coronary heart disease (PRIMULA Sweden) (2009)
- The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden (2009)
- Prevalence and incidence of Type 2 diabetes and its complications 1996-2003 (2008)
- Resource use and costs of type 2 diabetes in Sweden (2008)
- Characterization of Cellular Immunology in LADA Patients
Böcker
Konferenser
